Skip to contentI
International Stem Cell CORP
I
ISCOInternational Stem Cell CORP Released Mar 26, 2013, before the open
10-K filed Mar 26, 2013, 85 days after period end · 0001193125-13-125364
Q4 2012 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.25M$1.25Mderived+17.5% vs Q4 2011 No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
+5.1% vs Q3 2012
Net Income-$2.60M-$2.60MderivedN/M vs Q4 2011N/M vs Q3 2012 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$2,591,000N/M Margins · derivedOperating margin-207.8%+66.1 pt vs Q4 2011
Net margin-208.3%+38.8 pt vs Q4 2011
ended Dec 31, 2012 · filed Mar 26, 2013 · 85 d after period end